CORONAVIRUS SUPPORT If your cancer treatment has been suspended due to COVID-19, we can help. Our personalised cancer therapeutics offer precisely tailored treatment recommendations to increase your chances of success. Learn More

Personalised Cancer Therapeutics. Intelligently Designed.

Technology pioneered at the Mount Sinai School of Medicine

PDP-logo-with-Trademark.png
PDP .jpg

The Personal Discovery Process (PDP) provides individuals with treatment-driven research on an unprecedented scale. It is effectively a massive clinical trial for a single patient. We engineer the genetic complexity of each patient's unique tumour network into an army of 400,000 fruit fly "avatars". Using robotics, we evaluate up to 2,000 FDA approved drugs including non-cancer drugs, to identify drug combinations that are efficacious in the individual's avatar population.

The Icahn School of Medicine at Mount Sinai developed the PDP methodology over years of clinical research. They found that real-world patient tumours are made resistant to single-drug treatments by mutations in several genes, including genes not previously associated with cancer. Such resistant tumours can, however, be effectively addressed with novel combinations of FDA approved drugs. The most effective combinations almost always include non-cancer drugs. The Personal Discovery Process methods are licensed exclusively to My Personal Therapeutics.

Global Network

Collaborating with the innovators of tomorrow

As Featured In


Backed by

Where you can meet us next

Health Hub Vienna - Innovation Day at The Association of Austrian Social Security Institutions
September 17, 2020

AN OPEN INNOVATION PLATFORM WHERE ACADEMIC, HEALTHSERVICE PROVIDERS AND CORPORATE PARTNERS COLLABORATE AND PROVIDE THEIR EXPERTISE TO DRIVE CHANGE IN HEALTHCARE BY JOINING FORCES

Undruggable Leaders Virtual Forum 2020 - Unlocking the previously "undruggable"
September 22 - 23, 2020

BRINGING TOGETHER SENIOR R&D AND BUSINESS EXECUTIVES FROM ACROSS THE INDUSTRY TO PROVIDE NETWORKING AND COLLABORATION OPPORTUNITIES
Panelist - Laura Towart, Founder & CEO, My Personal Therapeutics

AIM HI Accelerator Fund - Women's Venture Competition
September 24, 2020

A FIRST-OF-ITS-KIND VENTURE COMPETITION FOR WOMEN ENTREPRENEURS LEADING INNOVATIVE EARLY-STAGE CANCER-FOCUSED PROJECTS

Oncology Convention Birmingham 2020
March 9 - 10, 2021

DEVELOPMENT OF PERSONALISED TREATMENT RECOMMENDATIONS FOR COLORECTAL CANCER PATIENTS - Dr. NAHUEL VILLEGAS & LAURA TOWART

Ready to get started?


Contact us now and we'll get you started.
Alternatively, you can visit the patient, physician and biopharma pages to learn more.